Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Brinker International, Inc. (EAT) - free report >>
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Brinker International, Inc. (EAT) - free report >>
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
Image: Bigstock
New Strong Buy Stocks for November 22nd
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Rigel Pharmaceuticals, Inc. (RIGL - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 26.9% over the last 60 days.
Rigel Pharmaceuticals, Inc. Price and Consensus
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
BrainsWay Ltd. (BWAY - Free Report) : This commercial stage medical device company has seen the Zacks Consensus Estimate for its current year earnings increasing 30.6% over the last 60 days.
Brainsway Ltd. Sponsored ADR Price and Consensus
Brainsway Ltd. Sponsored ADR price-consensus-chart | Brainsway Ltd. Sponsored ADR Quote
AvidXchange Holdings, Inc. (AVDX - Free Report) : This fintech company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
AvidXchange Holdings, Inc. Price and Consensus
AvidXchange Holdings, Inc. price-consensus-chart | AvidXchange Holdings, Inc. Quote
ImmunoGen, Inc. : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 116.7% over the last 60 days.
ImmunoGen, Inc. Price and Consensus
ImmunoGen, Inc. price-consensus-chart | ImmunoGen, Inc. Quote
Brinker International, Inc. (EAT - Free Report) : This casual dining restaurant company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.
Brinker International, Inc. Price and Consensus
Brinker International, Inc. price-consensus-chart | Brinker International, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.